通过隐私保护记录链接结合现实世界和临床试验数据:机遇和挑战-叙述审查
Michael Batech1, Ann Madsen1, Nicolle Gatto1
1Aetion Inc. New York City New York USA.
Health science reports
|September 25, 2025
概括
隐私保护记录链接 (PPRL) 可以整合随机临床试验 (RCT) 和现实世界数据 (RWD) 来增强临床研究. 这种方法为患者的旅程提供了更全面的视图,改善了药物开发和决策.
科学领域:
- 临床研究方法论临床研究方法论
- 医疗信息学 医疗信息学
- 数据科学是数据科学.
背景情况:
- 随机临床试验 (RCT) 面临的有效性挑战是由于参与者 attrition.
- 现实世界数据 (RWD) 提供了互补的见解,但通常与RCT脱节.
- 保护隐私的记录链接 (PPRL) 正在成为整合不同数据源的方法.
研究的目的:
- 探索PPRL在临床研究中的潜在用例.
- 通过数据集成解决RCT和RWD的局限性.
- 通过提高数据的全面性,为监管决策提供信息.
主要方法:
- 这个手稿是一个叙事评论.
- 它综合了现有文学中的关键概念.
- 没有收集或分析初级研究数据.
主要成果:
- PPRL可以创建一个整体的病人医疗互动的视图.
- 链接数据可以识别药物反应预测因子,减少患者负担.
- 应用包括创新的试验设计和全面的患者数据存储库.
结论:
- 通过PPRL整合RCT和RWD对药物开发具有重大潜力.
- 这种整合可以降低运营成本并增加数据可用性.
- 进一步探索PPRL使用案例可以推动创新的试验设计并改善决策.
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Purpose of Health Records I
1.7K
The vital purpose of health records is to provide a complete and accurate account of a patient's medical history, including communication, diagnostic and therapeutic orders, care planning, research, and quality review.
Here's a breakdown of how health records serve these purposes:
Here's a breakdown of how health records serve these purposes:
1.7K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Hazard Ratio
561
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
561


